Movement Alert｜Danaher Intraday Rise 3.06%, RBC Raises Price Target to $250
Market Focus
Oct 06
On October 6, Danaher rose 3.06% in Regular Trading, trading at $220.55 per share, with Turnover of $220 million.
RBC Capital Markets increased Danaher's price target to $250 from $215, citing progress in its biotechnology segment and expectations for faster diagnostics growth amid federal flu forecasts.
The bank noted that Danaher's premium valuation multiple has normalized after recent leadership changes, acknowledging the company's market leadership position in bioprocessing technologies with positive industry commentary supporting the outlook.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.